Literature DB >> 55786

Efficacy of antihypertensive drugs.

G T Dixon, E S Johnson.   

Abstract

The magnitude of the fall in blood-pressure in response to an antihypertensive drug depends on the level of the pretreatment pressure, and there is a direct relationship between the two in that the higher the pretreatment pressure the greater the fall in pressure in response to treatment. This simple relationship is inherent in the practical situation of titrating the diastolic blood-pressures of a group of hypertensive patients to a predetermined level. It is assumed that notionally the dose of an antihypertensive drug can be increased in all patients until the diastolic pressure is reduced to the predetermined level. When the fall in diastolic pressure (deltaD.P.) is plotted against pretreatment diastolic pressure (P.T.D.P.), the points for all patients lie on a straight line of slope unity and negative deltaD.P.-intercept numerically equal to the predetermined diastolic-pressure level. This straight-line relationship is termed the predetermined ideal response line. Analysis of data from clinical trials shows that, despite the variability inherent in the practical situation, the data appear to conform to this straight-line relationship. The method of assessing the efficacy of antihypertensive agents is essentially a comparison of each experimental point with the theoretical predetermined response line. In its simplest form the method consists in constructing a scatter diagram of deltaD.P. against P.T.D.P. for all patients. Patients can then be classified as responders or non-responders according to their position on the diagram relative to the predetermined response line. This method of assessing the efficacy of antihypertensive agents has several advantages, the most important of which is that it provides a simple method for displaying all the relevant information in a readily comparable form.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55786     DOI: 10.1016/s0140-6736(76)90299-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  The hemodynamic properties of amlodipine in anesthetised and conscious dogs: comparison with nitrendipine and influence of beta-adrenergic blockade.

Authors:  M G Dodd; D G Gardiner; A J Carter; M R Sutton; R A Burges
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

2.  The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man.

Authors:  C Zoccali; J R Zabludowski; C G Isles; G D Murray; G C Inglis; J I Robertson; R Fraser; S G Ball
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

3.  A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.

Authors:  D J Pugsley; M Nassim; B K Armstrong; L Beilin
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

4.  Self-recording of blood pressure in the management of hypertension.

Authors:  A L Johnson; D W Taylor; D L Sackett; C W Dunnett; A G Shimizu
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

Review 5.  Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

6.  Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy.

Authors:  Raafat Al Ghoneim; Abdalla Kamal Omar; Vj Sebastian; Roland Kassab; George Akijian; Meryem Hafiz; Birgit Schmidt
Journal:  Integr Blood Press Control       Date:  2013-06-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.